Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine

BACKGROUND: In 2003, severe acute respiratory syndrome (SARS) resulted in hundreds of infections and deaths globally. We aim to assess immunogenicity and protective efficacy of purified inactivated Vero-cell SARS vaccine in monkeys. METHODS: The cultures of SARS coronavirus (SARS-CoV) BJ-01 strain i...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Ede, Shi, Huiying, Tang, Lin, Wang, Cuie, Chang, Guohui, Ding, Zhifen, Zhao, Kai, Wang, Jian, Chen, Ze, Yu, Man, Si, Bingyin, Liu, Jianyuan, Wu, Donglai, Cheng, Xiaojie, Yang, Baoan, Peng, Wenming, Meng, Qingwen, Liu, Bohua, Han, Weiguo, Yin, Xunnan, Duan, Hongyuan, Zhan, Dawei, Tian, Long, Li, Shuangli, Wu, Jinsong, Tan, Gang, Li, Yi, Li, Yuchuan, Liu, Yonggang, Liu, Hong, Lv, Fushuang, Zhang, Yu, Kong, Xiangang, Fan, Baochang, Jiang, Tao, Xu, Shuli, Wang, Xiaomei, Li, Changwen, Wu, Xiaohong, Deng, Yongqiang, Zhao, Min, Zhu, Qingyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2006
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115602/
https://www.ncbi.nlm.nih.gov/pubmed/16388880
http://dx.doi.org/10.1016/j.vaccine.2005.06.038

Ejemplares similares

Ejemplares similares